Skip to Content

B 796 (Rivastigmine Tartrate 6 mg)

Pill with imprint B 796 is Orange / Red, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 796

Rivastigmine Tartrate

Imprint
B 796
Strength
6 mg
Color
Orange / Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0796

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.